Experienced in Temporal Arteritis

Dr. Andras Perl

Rheumatology
Department Of Medicine Medical Serv Grp At Suny Hlth Sci Ctr Syr In
4900 Broad Rd, 
Syracuse, NY 
Experienced in Temporal Arteritis
Department Of Medicine Medical Serv Grp At Suny Hlth Sci Ctr Syr In
4900 Broad Rd, 
Syracuse, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Andras Perl is a Rheumatologist in Syracuse, New York. Dr. Perl is rated as an Experienced provider by MediFind in the treatment of Temporal Arteritis. His top areas of expertise are Systemic Lupus Erythematosus (SLE), Psoriatic Arthritis, Discoid Lupus Erythematosus (DLE), Psoriasis, and Thymectomy.

His clinical research consists of co-authoring 99 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Temporal Arteritis.

Specialties
Rheumatology
Licenses
Internal Medicine in NY
Hospital Affiliations
Crouse Hospital
University Hospital S U N Y Health Science Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

DEPARTMENT OF MEDICINE MEDICAL SERV GRP AT SUNY HLTH SCI CTR SYR IN
4900 Broad Rd, Syracuse, NY 13215
Other Locations
DEPARTMENT OF MEDICINE MEDICAL SERV GRP AT SUNY HLTH SCI CTR SYR IN
1000 E Genesee St, Suite 403, Syracuse, NY 13210
DEPARTMENT OF MEDICINE MEDICAL SERV GRP AT SUNY HLTH SCI CTR SYR IN
750 E Adams St, Syracuse, NY 13210

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Two-Arm, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of LY3361237 as a Treatment for Adults With At Least Moderately Active Systemic Lupus Erythematosus
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Two-Arm, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of LY3361237 as a Treatment for Adults With At Least Moderately Active Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 20, 2025
Intervention Type: Drug
Study Drug: LY3361237
Study Phase: Phase 2
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: July 23, 2024
Intervention Type: Drug, Other
Study Drug: VIB7734
Study Phase: Phase 2
A Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TAK-079 in Combination With Standard Background Therapy in Patients With Moderate to Severe Systemic Lupus Erythematosus
A Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TAK-079 in Combination With Standard Background Therapy in Patients With Moderate to Severe Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: March 29, 2024
Intervention Type: Drug
Study Drug: TAK-079
Study Phase: Phase 1
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 23, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE
A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE
Enrollment Status: Terminated
Publish Date: April 12, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

99 Total Publications

IgG and IgM Anti-Phosphatidylserine/Prothrombin Complex Antibody Detection May Improve Classification Accuracy of Systemic Lupus Erythematosus and Antiphospholipid Antibody Syndrome.
IgG and IgM Anti-Phosphatidylserine/Prothrombin Complex Antibody Detection May Improve Classification Accuracy of Systemic Lupus Erythematosus and Antiphospholipid Antibody Syndrome.
Journal: ACR open rheumatology
Published: August 06, 2025
Similar Doctors
Advanced in Temporal Arteritis
Dr. Hom P. Neupane
Rheumatology
Advanced in Temporal Arteritis
Dr. Hom P. Neupane
Rheumatology

Department Of Medicine Medical Serv Grp At Suny Hlth Sci Ctr Syr In

1000 E Genesee St, Suite 403, 
Syracuse, NY 
 (3.1 miles away)
315-464-2929
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Hom Neupane is a Rheumatologist in Syracuse, New York. Dr. Neupane is rated as a Distinguished provider by MediFind in the treatment of Temporal Arteritis. His top areas of expertise are Undifferentiated Connective Tissue Disease (UCTD), Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA), and Fibromyalgia.

Advanced in Temporal Arteritis
Dr. Jianghong J. Yu
Rheumatology
Advanced in Temporal Arteritis
Dr. Jianghong J. Yu
Rheumatology

Department Of Medicine Medical Serv Grp At Suny Hlth Sci Ctr Syr In

750 E Adams St, 
Syracuse, NY 
 (2.7 miles away)
315-464-4457
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jianghong Yu is a Rheumatologist in Syracuse, New York. Dr. Yu is rated as a Distinguished provider by MediFind in the treatment of Temporal Arteritis. Her top areas of expertise are Undifferentiated Connective Tissue Disease (UCTD), Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, and Rheumatoid Arthritis (RA).

Advanced in Temporal Arteritis
Dr. Ute H. Dreiner
Rheumatology
Advanced in Temporal Arteritis
Dr. Ute H. Dreiner
Rheumatology

Slocum Dickson Medical Group PLLC

1729 Burrstone Rd, 
New Hartford, NY 
 (45.2 miles away)
315-798-1500
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ute Dreiner is a Rheumatologist in New Hartford, New York. Dr. Dreiner is rated as a Distinguished provider by MediFind in the treatment of Temporal Arteritis. Her top areas of expertise are Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, Rheumatoid Arthritis (RA), and Sjogren Syndrome.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Perl's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 22 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile